390
Participants
Start Date
December 31, 1998
Primary Completion Date
August 31, 2005
Study Completion Date
August 31, 2005
anti-thymocyte globulin
filgrastim
busulfan
cyclophosphamide
methylprednisolone
umbilical cord blood transplantation
radiation therapy
North Shore University Hospital, Manhasset
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
Children's Hospital of Pittsburgh, Pittsburgh
Duke Comprehensive Cancer Center, Durham
Cincinnati Children's Hospital Medical Center, Cincinnati
Spectrum Health and DeVos Children's Hospital, Grand Rapids
University of Minnesota Cancer Center, Minneapolis
Cardinal Glennon Children's Hospital, St Louis
Children's Mercy Hospital, Kansas City
Children's Hospital of New Orleans, New Orleans
Medical City Dallas Hospital, Dallas
Children's Hospital of Orange County, Orange
Fred Hutchinson Cancer Research Center, Seattle
City of Hope Comprehensive Cancer Center, Duarte
Children's Hospital Los Angeles, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
Children's National Medical Center, Washington D.C.
Indiana University Cancer Center, Indianapolis
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda
Warren Grant Magnuson Clinical Center, Bethesda
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Cancer Center at Hackensack University Medical Center, Hackensack
Ireland Cancer Center, Cleveland
National Cancer Institute (NCI)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Fred Hutchinson Cancer Center
OTHER